Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc, a global leader in consumer health, covers the month of September 2024. The report specifically details a transaction in the company's own shares executed on September 9, 2024, under a share buyback programme announced on August 1, 2024.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity figures. It focuses exclusively on share repurchase activity. Key metrics from the transaction include:
- Shares Purchased: 510,800 ordinary shares
- Price Range: Lowest 390.00 pence; Highest 392.40 pence
- Volume Weighted Average Price: 391.5297 pence
- Post-Transaction Share Capital: 9,121,378,772 ordinary shares
Material Changes
The primary material change is the reduction of the company's registered share capital following the cancellation of the 510,800 purchased shares. No other material changes to financial performance or operations are disclosed in this specific filing.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on future performance, or discussion of risks and contingencies. It serves strictly as a regulatory disclosure of a completed share transaction in compliance with the Market Abuse Regulation (Article 5s(1)(b)).
Investor Verification Checklist
- Verify the total number of shares repurchased to date under the August 2024 Buyback Programme.
- Confirm the current total share capital of 9,121,378,772 shares against the latest market data.
- Review the full trade breakdown available via the provided London Stock Exchange link for granular transaction details.
- Check if the share price paid (approx. 391.5 pence) aligns with the market price on September 9, 2024.